We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$335B
AUM Growth
+$21B
Cap. Flow
-$4B
Cap. Flow %
-1.19%
Top 10 Hldgs %
21.52%
Holding
3,670
New
323
Increased
1,420
Reduced
1,524
Closed
323

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.66B
2
BABA icon
Alibaba
BABA
+$881M
3
INTC icon
Intel
INTC
+$783M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$783M
5
LIN icon
Linde
LIN
+$667M

Sector Composition

Rank Sector Weight
1 Technology 23.77%
2 Financials 13.03%
3 Consumer Discretionary 12.7%
4 Healthcare 12.61%
5 Communication Services 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVAX
2051
DELISTED
Dynavax Technologies
DVAX
$7.1M ﹤0.01%
721,046
+249,867
+53% +$2.27M
BFLY icon
2052
Butterfly Network
BFLY
$2.35B
$7.09M ﹤0.01%
+489,334
New +$6.61M
CBZ icon
2053
CBIZ
CBZ
$2.96B
$7.07M ﹤0.01%
215,720
+6,797
+3% +$227K
TUP
2054
DELISTED
Tupperware Brands Corporation
TUP
$7.06M ﹤0.01%
297,342
+67,193
+29% +$1.7M
NWBI icon
2055
Northwest Bancshares
NWBI
$2.28B
$7.04M ﹤0.01%
516,148
+8,652
+2% +$122K
KAI icon
2056
Kadant
KAI
$3.99B
$6.99M ﹤0.01%
39,690
-5,480
-12% -$965K
VPG icon
2057
Vishay Precision Group
VPG
$914M
$6.99M ﹤0.01%
205,210
-13,471
-6% -$447K
USPH icon
2058
US Physical Therapy
USPH
$1.22B
$6.95M ﹤0.01%
59,964
+8,342
+16% +$958K
COLL icon
2059
Collegium Pharmaceutical
COLL
$956M
$6.94M ﹤0.01%
293,712
+26,265
+10% +$607K
NEU icon
2060
NewMarket
NEU
$8.18B
$6.94M ﹤0.01%
21,551
-6,346
-23% -$2.22M
ATOS icon
2061
Atossa Therapeutics
ATOS
$23.5M
$6.93M ﹤0.01%
+73,142
New +$3.87M
MYE icon
2062
Myers Industries
MYE
$1.29B
$6.93M ﹤0.01%
330,035
+1,055
+0.3% +$22.6K
MATW icon
2063
Matthews International
MATW
$739M
$6.92M ﹤0.01%
192,404
+24,262
+14% +$969K
MORF
2064
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$6.9M ﹤0.01%
120,292
+51,844
+76% +$2.85M
RDUS
2065
DELISTED
Radius Health, Inc.
RDUS
$6.87M ﹤0.01%
376,667
-43,658
-10% -$868K
AERI
2066
DELISTED
Aerie Pharmaceuticals
AERI
$6.86M ﹤0.01%
428,637
+66,692
+18% +$1.14M
BOH icon
2067
Bank of Hawaii
BOH
$3.13B
$6.86M ﹤0.01%
81,437
+416
+0.5% +$37.3K
TGH
2068
DELISTED
Textainer Group Holdings limited
TGH
$6.84M ﹤0.01%
202,649
-21,077
-9% -$623K
TRS icon
2069
TriMas Corp
TRS
$1.44B
$6.82M ﹤0.01%
224,820
-18,789
-8% -$596K
TBI
2070
Trueblue
TBI
$311M
$6.82M ﹤0.01%
242,475
+69,331
+40% +$1.85M
AAN
2071
DELISTED
The Aaron's Company Inc
AAN
$6.78M ﹤0.01%
211,837
+32,747
+18% +$1.03M
PAE
2072
DELISTED
PAE Incorporated Class A Common Stock
PAE
$6.78M ﹤0.01%
761,221
+226,139
+42% +$1.94M
AER icon
2073
AerCap
AER
$23.8B
$6.77M ﹤0.01%
132,116
-1,619
-1% -$93.4K
BHE icon
2074
Benchmark Electronics
BHE
$2.96B
$6.76M ﹤0.01%
237,419
+35,569
+18% +$1.07M
CRVL icon
2075
CorVel
CRVL
$3.19B
$6.7M ﹤0.01%
149,559
+19,932
+15% +$787K

Similar funds

Nuveen's Q2 2021 Portfolio in Review

As of Q2 2021, Nuveen held 3,670 positions worth $335B, up 6.7% from $314B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2021 filing shows 323 new, 1,420 increased, 1,524 reduced and 323 closed positions. Its largest new stake was UiPath: 2,457,331 shares worth $167M. The largest sale was Apple, an estimated $1.66B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2021 buy was UiPath: 2,457,331 shares worth $167M.
  • Nuveen added most to Wells Fargo in Q2 2021, an estimated $512M increase.
  • Nuveen's biggest Q2 2021 reduction was Apple, cutting an estimated $1.66B.
  • Nuveen fully exited SolarEdge in Q2 2021, selling an estimated $66M.
  • Nuveen's ten largest holdings make up 22% of its $335B portfolio in Q2 2021.
  • Nuveen opened 323 new positions and closed 323 in Q2 2021.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $335B.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.